Calcium stone disease: an overview.
D001581:Benzothiadiazines; D001862:Bone Resorption; D002118:Calcium / Q000378:metabolism*; D002129:Calcium Oxalate / Q000652:urine; D002130:Calcium Phosphates / Q000652:urine; D002136:Calcium, Dietary / Q000008:administration & dosage; D003460:Crystallization; D004232:Diuretics; D005440:Fluid Therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007669:Kidney Calculi / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D007684:Kidney Tubules / Q000378:metabolism; D010280:Parathyroid Glands / Q000503:physiopathology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014527:Uric Acid / Q000652:urine
D001581:Benzothiadiazines; D002130:Calcium Phosphates; D002136:Calcium, Dietary; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D002129:Calcium Oxalate; D014527:Uric Acid; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002118:Calcium